Autopsy report · NCT00979771

A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Cancelled Before Active”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: GlaxoSmithKline
Sponsor type: Industry
Conditions: Arthritis, Rheumatoid
Interventions: GSK706769; Placebo
Participants: 0
Sites: 1
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.